Paracetamol maker Granules India posts 23 per cent rise in Q3 profit, Health News, ET HealthWorld

Bengaluru: Pharmaceutical company Granules India Ltd, reported a 23 per cent rise in third-quarter profit on Tuesday, propelled by strong demand for the painkiller drug Paracetamol. Consolidated profit rose to 1.24 billion rupees ($15.22 million) for the three months ended Dec. 31, from 1.01 billion rupees a year earlier. Consolidated revenue for the company rose nearly 15 per cent to 11.46 billion rupees, “primarily driven by higher Paracetamol API sales in the US,” the company said in an exchange filing. “Opportunities in Paracetamol are likely to continue and our geography…

Read More